Prostatic adenoma and overactive urinary bladder: assessment of symptoms and choice of therapy


Cite item

Full Text

Abstract

References

  1. Speakman M. J., Kirby R. S., Joyce A. et al. Guideline for the primary care management of male lower urinary tract symptoms. Br. J. Urol. Int. 2004; 93 (7): 985-990.
  2. Roehrborn C. G. et al. Focus on lower urinary tract symptoms: Nomenclature, diagnosis, and treatment options. Highlights from the 5-th International consultation on benign prostatic hyperplasia. June 25-27, 2000, Paris, France. Rev. Urol. 2001; 3 (3): 139-145.
  3. Сивков А. В., Аполихин О. И., Патаки К. В. Современный алгоритм обследования и лечения больных доброкачественной гиперплазией предстательной железы. Consilium Medicum 2004; 6 (7).
  4. Chapple C. R. Pharmacological therapy of benign prostatic hyerpolasia/low urinary tract symptoms: the overview for the practicing clinician. Br. J Urol. Int. 2004; 94: 738-744.
  5. Speakman M. Efficacy and safety of tamsulosin OCAS. Br. J. Urol. Int. 2006; 98 (suppl. 2): 13-17.
  6. McVary K. T., McKenna K. E. The relationship between erectile dysfunction and low urinary tract symptoms: epidemiological, clinical, and basic science evidence. Curr. Urol. Rep. 2004; 5: 251-257.
  7. Roseb R., Altwein J., Boyle P. et al. Lower urinary tract symptoms and male sexual dysfunction: the Multinational Survey of Aging Male (MSAM-7). Eur. Urol. 2003; 44: 637-649.
  8. Knutson T., Edlund C., Fall M. et al. BPH with coexisting overactive bladder dysfunction - an everyday urological dilemma. Neurourol. and Urodyn. 2001; 20: 237-247.
  9. Dmochowski R., Staskin D. OAB in men: special considerations for evaluation and management. Urology 2002; 60 (5, suppl. 1): 56-62.
  10. Kaplan S. A., Walmsley K., Te A. E. Use of muscarinic receptor antagonist as monotherapy in men with lower urinary tract symptoms who failed previous therapy with alpha blockers. J. Urol. (Baltimore) 2004; 171: 243.
  11. Abrams P., Kaplan S. A., De Koning Gans H. J., Millard R. Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction. J. Urol. (Baltimore) 2006; 175 (3, pt 1): 999-1004.
  12. Milsom I., Abrams P., Cardoso L. et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. Br. J. Urol. Int. 2001; 87 (9): 760-766.
  13. Girman C. J., Jacobsen S. J., Tsukamoto T. et al. Health-related quality of life associated with low urinary tract symptoms in four countries. Urology 1998; 51: 428-436.
  14. Eckhard M. D., van Venrooij G. E. P. M., Boon T. A. Symptoms and quality of life versus age, prostate volume, and urodynamic parameters in 565 men with low urinary tract symptoms suggestive to benign prostatic hyperplasia. Urology 2001; 57: 695-700.
  15. Hyman M. J., Groutz A.l, Blaivas J. G. Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings. J. Urol. (Baltimore) 2001; 166: 550-553.
  16. Kaplan S. A., Bowers D. L., Te A. E., Olsson C. A. Differential diagnosis of prostatism: a 12-year retrospective analysis of symptoms, urodynamics, and satisfaction with therapy. J. Urol. (Baltimore) 1996; 155: 1305-1308.
  17. Greenland J. E., Brading A. F. The effect of bladder outflow obstruction on detrusor blood flow changes during the voiding cycle in conscious pigs. J. Urol. (Baltimore) 2001; 165: 245-248.
  18. Harrison S. C., Hunnam G. R., Farman P. et al. Bladder instability and denervation in patients with bladder outflow obstruction. Br. J. Urol. 1987; 60: 519-522.
  19. Mirone V., Imbimbo C., Sessa G. et al. Correlation between detrusor collagen content and urinary symptoms in patients with prostatic obstruction. J. Urol. (Baltimore) 2004; 172: 1386-1389.
  20. Seki N., Karim O. M., Mostwin J. L. Changes in electrical properties of guinea pig smooth muscle membrane by experimental bladder obstruction. Am. J. Physiol. 1992; 262: F885-F891.
  21. Abrams P., Klevmark B. Frequency-volume charts: an indispensable part of low urinary tract assessment. Scand. J. Nephrol. 1996; suppl. 179: 47-53.
  22. Saito H., Yamada T., Oshima Y. et al. A comparative study of the efficacy and safety of tamsulosin hydrochloride alone and combination of propiverine hydrochloride and tamsulosin hydrochloride in the benign prostatic hypertrophy with pollakiutria and/or urinary incontinence. Jpn J. Urol. Surg. 1999; 12: 525-526.
  23. Athanasopoulos A., Gyftopoulos K., Giannitsas K. et al. Combination treatment with an alpha-blocker plus an anticholinergic for bladder out-let obstruction: a prospective, randomized, controlled study. J. Urol. (Baltimore) 2003; 169: 2253-2256.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2009 Bionika Media